Full-year 2025 revenues surpassed guidance, growing 10% year-over-year to reach $9.55 billion. This strong performance was ...
Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results